United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

18-21mmhg) thigh length open toe with sensitive band lymphoedema garment wide regular size ii caramel (bsn medical ltd -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

shermond -

United States - English - NLM (National Library of Medicine)

mylan institutional inc. - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - nifedipine extended-release tablets, usp are indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine extended-release tablets may also be used where the clinical presentation suggests a possible vasospastic component, but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion, or in unstable angina where electrocardiographic findings are compatible with intermittent vasospasm, or when angina is refractory to nitrates and/or adequate doses of beta blockers. nifedipine extended-release tablets are indicated for the management of

United States - English - NLM (National Library of Medicine)

cardinal health - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - nifedipine extended-release tablets, usp are indicated for the management of vasospastic angina confirmed by any of the following criteria: 1) classical pattern of angina at rest accompanied by st segment elevation, 2) angina or coronary artery spasm provoked by ergonovine, or 3) angiographically demonstrated coronary artery spasm. in those patients who have had angiography, the presence of significant fixed obstructive disease is not incompatible with the diagnosis of vasospastic angina, provided that the above criteria are satisfied. nifedipine extended-release tablets may also be used where the clinical presentation suggests a possible vasospastic component, but where vasospasm has not been confirmed, e.g., where pain has a variable threshold on exertion, or in unstable angina where electrocardiographic findings are compatible with intermittent vasospasm, or when angina is refractory to nitrates and/or adequate doses of beta blockers. nifedipine extended-release tablets are indicated for the management of

United States - English - NLM (National Library of Medicine)

strategic sourcing services llc - aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e) -

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

18-21mmhg) below knee open toe with silicone top band lymphoedema garment extra short size v cinnamon (juzo uk ltd -

Canada - English - Health Canada

liquid carbonic inc. - air - gas - 99% - air 99% - other miscellaneous therapeutic agents

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

baxter corporation - dextrose - solution - 50 %

Saudi Arabia - English - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

accord healthcare s.l.u, spain - pegfilgrastim - solution for injection in pre-filled syringe - 10 mg/ml,

Ireland - English - HPRA (Health Products Regulatory Authority)

intervet ireland limited - f11-antigen suspension, ft-antigen suspension - emulsion for injection - %v/v - escherichia vaccine - fowl - chicken - immunological - inactivated vaccine